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Association was investigated between oral health before dialysis and the incidence of 
systemic infections during dialysis. We hypothesized that low-grade systemic 
inflammation caused by poor oral health associates with infectious episodes in patients on 
dialysis, despite earlier eradication of oral infection foci. 
Subjects and methods 
117 patients (46 with peritoneal and 71 with hemodialysis) were examined and treated at 
predialysis stage and followed-up during dialysis. Number of infection episodes and 
microorganisms cultured from blood and peritoneal fluid were analyzed. Number of teeth, 
Periodontal Inflammatory Burden and Total Dental Index scores were assessed and 
salivary matrix metalloproteinase 8, triggering receptor on myeloid cells 1, peptidoglycan 
recognition protein 1 (PGLYRP1), and interleukin-1β were measured. 
Results 
In hemodialysis, 134 infection episodes were recorded, while peritoneal dialysis group had 
77 peritonitis episodes. Culture-negative samples were 69 % in hemodialysis and 23 % in 
peritoneal dialysis group. Staphylococci were the most frequently associated micro-
organisms. Infections during dialysis did neither associate with oral health parameters 
nor with salivary inflammatory biomarkers, except for PGYLRP1, which associated with 
number of infection episodes during hemodialysis (p=0.046). 
Conclusions 
Number of infection episodes during hemodialysis were associated with salivary PGYLRP1 




Patients with chronic kidney disease (CKD) on hemodialysis (HD) or peritoneal dialysis (PD) 
are susceptible to infections associated with high morbidity and mortality. Against matched 
general population controls, mortality hazard ratios have been reported to be 12.6 for HD 
patients and 9.2 for PD patients, respectively (Neovius, Jacobson, Eriksson, Elinder, & 
Hylander, 2014). Infections are common in both HD and PD patients, mainly because the 
skin barrier iinterrupted during the treatment.  
HD patients have higher incidence of bloodstream infections compared with PD 
patients, accounting for a substantial number of hospitalizations (Patel, Kallen, & Arduino, 
2010). HD vascular access device (HVAD) infection rate has been estimated to average 3.5 
cases per 100 months (Rojas et al., 2013; Tokars et al., 2001). The most common bacteria 
isolated from the HD infections are coagulase negative staphylococci 
(CONS) and Staphylococcus aureus (Berman et al., 2004; Tokars et al., 2001). 
  
PD is associated with infection of the peritoneum, with overall reported infection rate being 
0.364 per dialysis year (Nessim, Bargman, & Jassal, 2010). In PD patients, peritonitis 
remains the most common cause for dialysis modality change from PD to HD. Peritonitis is 
most commonly caused by Gram-positive bacteria which canmigrate from the skin and 
colonize the PD catheter from a failure to follow sterile precautions when performing the PD 
exchanges (Li et al., 2016). S. epidermidis and other CONS are common bacteria in PD-
associated infections (Liakopoulos et al., 2017). 
  
Periodontal disease has been shown to associate with CKD (Deschamps-Lenhardt, Martin-
Cabezas, Hannedouche, & Huck, 2019; Nylund et al., 2018, 2017; Ruokonen et al., 2017) . 
Combined with the knowledge that bacteremia or soluble bacterial products originating from 
the mouth can disseminate to distant sites, we set to investigate the association between 
oral diseases and dialysis-related infections (Bahrani-Mougeot et al., 2008; Lockhart et al., 
2008; Lockhart & Durack, 1999; Meurman & Hämäläinen, 2006; Scannapieco, 1998). 
  
To date, there are only few studies on the association between oral bacteria and dialysis 
infections, with two of such studies focusing on HVAD infections (D’Amato-Palumbo, 
Kaplan, Feinn, & Lalla, 2013; Shariff et al., 2004). These studies have failed to show a link 
between oral infections and dialysis-related complications. Both these studies have focused 
on bacterial analyses but lack the data on the actual oral health condition. A more recent 
study showed an association between PD-related peritonitis and oral hygiene habits but no 
connection between PD-related infections and the oral health status had been 
addressed (Oka et al., 2018). 
  
As treatment of end-stage CKD aims towards kidney transplantation, the current policy in 
our hospital is to eradicate all possible dental infectious foci prior to commencing dialysis. 
The aim of the present study was to investigate the association between oral health 
status before dialysis initiation and the incidence of systemic infections during dialysis. The 
overall study hypothesis was that long-lasting low-grade systemic inflammatory 
burden caused by poor oral health associates with infectious episodes in patients on 
dialysis, even though oral infection foci had been eradicated at predialysis stage. 
  
MATERIALS AND METHODS 
  
Ethical committee of the Helsinki and Uusimaa Hospital District, Finland had approved the 




This is an observational study on 117 patients (70.9% men, 29.1% women; aged 23–83 
years) with CKD, followed-up at the Departments of Nephrology and Oral and Maxillofacial 
Diseases of the Helsinki University Hospital, Helsinki, Finland between the years 2000 
and 2015. Details of the baseline examinations have been published earlier (Nylund et al., 
2015; Vesterinen, Ruokonen, Furuholm, Honkanen, & Meurman, 2011). In brief, 144 CKD 
patients were examined and treated at predialysis stage with emphasis on periodontal 
inflammatory burden. Inclusion criteria were estimated glomerular infiltration rate 
(eGFR) below 20ml/min, corresponding to advanced CKD stage 4 and 5. We excluded from 
the analysis of the original cohort 27 patients for the following reasons: 14 died before 
initiating dialysis, three patients never started dialysis treatment, and 10 patients were lost 
in follow-up. For dialysis stage, out of the remaining 117 patients, 46 patients were initially 
settled for peritoneal and 71 patients for hemodialysis. Patients were followed up until kidney 
transplantation, patient death, or until December 31st, 2015. Six patients changed 
dialysisode from PD to HD during the follow-up, and there were no switches from HD to PD. 
During the follow-up, 51 patients deceased. Records pertaining to kidney transplantation 
and patient mortality have been published earlier (Nylund et al., 2018; Ruokonen et al., 
2017). Study design is summarized in figure 1. 
  
Oral examinations and treatment 
All patients underwent a full clinical examination by same periodontist (Dr. Hellevi 
Ruokonen) and a panoramic radiographic examination, as outlined in earlier articles (Nylund 
et al., 2015; Vesterinen et al., 2011). Following these examinations, 
a therapeutic eradication of all infectious dental foci was performed, according to the 
Helsinki University Hospital guidelines. All non–restorable teeth were extracted; these 
included teeth with abscesses, cysts, severe periodontitis with more than 6 mm periodontal 
pocket depth after intensive periodontal therapy and marked alveolar bone loss seen in the 
radiographs, teeth with acute or undisputed chronic periapical disease findings, severely 
carious teeth where the cavity reached the dental pulp, root remnants, and wisdom teeth 
with pericoronitis.  
  
The following indices were calculated from the dental records and categorized into two 
groups by medians: Number of teeth was calculated from the dental records. Total Dental 
Index (TDI) was calculated from all teeth, taking into account caries, periodontitis, periapical 
and pericoronitis lesions. The index ranges from 0 to 10 (Mattila et al., 1989). Periodontal 
inflammatory burden index (PIBI) was calculated from 28 teeth. The PIBI index combines 
the data on periodontal probing depth and is calculated by adding the number of moderate 
pockets to the weighted number of periodontal sites indicating advanced periodontitis(Lindy, 
Suomalainen, Mäkelä, & Lindy, 2008). 
  
Pro-inflammatory biomarkers matrix metalloproteinase (MMP)-8, triggering receptor on 
myeloid cells 1 soluble form (sTREM-1), peptidoglycan recognition protein 1 (PGLYRP1), 
and interleukin (IL)-1β were analyzed from the salivary samples. Salivary sTREM-1, 
PGLYRP1, and IL-1β were measured by commercially available specific ELISA kits in pre-
dialysis stage. Salivary MMP-8 was analyzed by time-resolved immunofluorometric assay 
(IFMA) using monoclonal MMP-8–specific antibodies as catching and tracing antibodies, 
respectively. The tracer antibody was labeled with europium-chelate. These baseline 
methods have been reported earlier (Nylund et al., 2015, 2017). 
  
After appropriate treatment, all patients were set on a personalized re-call schedule to 
maintain satisfactory oral health during follow-up. However, compliance was not 
followed when 53 patients (surviving patients as shown in Figure 1) were clinically assessed 
again at the end of the study period. Our earlier experience from this longitudinal 
study showed a significant improvement in the patients’ clinical oral health parameter when 
compared to baseline (Nylund et al., 2018). 
  
Systemic infections and microbiological analysis 
All infection episodes and results from blood and peritoneal fluid samples during dialysis 
were retrieved from the hospital records.  
  
We defined infectious episode in HD patients as the occurrence of febrile episode 
during a hemodialysis session, after excluding other, non-dialysis related infectious foci, 
such as respiratory tract infection or diabetic foot. A diagnosis of infection was based on the 
nephrologist’s discretion. By our hospital policy, blood samples are always taken for aerobic 
and anaerobic blood culture in such cases, before antimicrobial treatment is initiated.  
In PD-patients admitted to the nephrology ward suspected of peritonitis, PD-effluent 
samples with more 100 leucocytes/ml along with an appropriate clinical picture lead 
to antimicrobial treatment and diagnosis of peritonitis. Before antimicrobial therapy 
initiation, a PD-effluent sample was obtained for culture in aerobic and anaerobic blood 
culture bottles. Recurrent peritonitis occurring within one month of the previous episode 
was classified as a single infectious episode. 
  
Blood and peritoneal fluid samples were incubated in blood culture bottles according to 
standard procedures at Helsinki University Hospital Laboratory (HUSLAB) for a 
maximum of 5–6 days or until they became positive and the microbes were identified 
according to standard methods of the laboratory. 
  
Statistical analysis 
A software program IBM SPSS Statistics (version 25.0, IBM Corp., Armonk, N.Y., USA) was 
used for statistical analyses. Chi-square test was conducted for calculating associations 
between categorical variables and Spearman’s rank-order correlation to assess the 
relationship between continuous variables. For further analyses the continuous variables 
were transformed into dichotomous (high vs. low) by their median values and compared with 






Infections and microbial findings in HD patients 
HD patients were on dialysis for median time of 37 months (mean 47 months) before end of 
follow-up. Of the 71 HD patients, 44 had at least one or more infectionepisodes; 27 patients 
had no infections (median was 1, mean 1.89, range 0–14). In this study, the number of any 
infection during HD was divided into two groups by 0 vs. 1 or more infections. Time on 
dialysis correlated positively with the number of infectious episodes 
(Spearman’s ρ=0.445, p=0.004). 
  
Total number of infection episodes was 134. Of these, two infection episodes were 
polymicrobial, i.e. two bacterial species were discovered in blood culture. 94 infection 
episodes were culture-negative, with 94 blood culture-negative samples 
(69.1%). Patients had a total of 42 bacterial findings in blood culture samples within 40 
infection episodes. Gram-positive cocci comprised the largest group of bacterial findings, 
83.3% of all culture-positive samples. S. aureus (47.6%) and CONS (11.9%) were themost 
common bacterial findings. Table 1 provides listing of all microbial findings. 
  
Oral health parameters and systemic infections in HD patients 
No statistically significant associations could be found between the number of systemic 
infection episodes among the HD patients and scores of PIBI, TDI, or the number of 
teeth at predialysis stage. TDI could be calculated from only 66 out of 
71 HD patients because radiological analyses were not available from all the patients at the 
time of investigation. There was no statistically significant difference when comparing TDI 
values and the number of 
infection episodes (p=0.760). Table 2 provides therespective clinical values. 
  
Predialysis salivary proinflammatory biomarkers and systemic 
infection episodes in HD patients 
Salivary biomarker analysis was available from 54 out of 71 patients and 35 
patients of those  54 patients had at least one infection episode. In patients with one or 
more infection episodes, 21 patients had significantly higher PGLYRP1 concentrations 
(77.8%, divided by median) than the group with lower PGLYRP1 concentrations (N=14, 
51.9%, p=0.046). Similar trends were observed in the higher median salivary MMP-8, 
sTREM-1 and IL1β biomarker concentrations in patients with more infections, but the results 
were not statistically 
significant. Table 2 provides the mean salivary biomarker concentrations and the 
respective p values. 
  
PERITONEAL DIALYSIS  
  
Peritoneal infections and microbial findings in PD patients 
PD patients were on dialysis for a median time of 23 months (mean 31 months) before end 
of follow-up. Of the 46 peritoneal dialysis patients, 29 had at least one peritonitis episode 
while 17 patients had none. PD patients had a total of 77 infection episodes (median 1, 
mean 1.63, range 0–7). There was no significant correlation between the time on dialysis 
and the number of peritonitis episodes (Spearman’s ρ=0.105, p=0.651). 
  
Thirty-one PD patients had 77 peritonitis episodes. One infection was polymicrobial, with 
two bacteria identified. In PD patients 18 peritonitis episodes were culture-
negative, 23.1% (N=18) of all bacterial cultures. Patients had a total of 60 bacterial findings 
in blood culture samples. Similarly to HD-group, Gram-positive cocci made up most 
of the culture-positive samples, that was 75.0% of all culture-positive samples. The most 
frequent bacterial findings were S. aureus (20.0%) and CONS (38.3%).Table 1 provides 
listing of all microbial findings. 
  
Oral health parameters and peritonitis episodes in PD patients 
There was no statistically significant association between the number of peritonitis episodes 
and PIBI and TDI scores, respectively, nor between the number of teeth in PD group. TDI 
could be calculated from 38 out of 46 patients since radiological analyses were not available 
from all the patients at the time of 
investigation. Table 3provides the respective clinical parameter values. 
  
Predialysis salivary proinflammatory biomarkers and peritonitis 
Biomarker analysis was available from 36 out of 46 PD patients. Twenty-two from 36 had 
one or more peritonitis episodes. These patients had no statistically significant differences 
regarding salivary MMP-8, PGLYRP1, sTREM-1 or IL-1β levels in relation to the 
patients without peritonitis episodes. No statistically significant associations were 
found with respect to the number of peritonitis episodes in this 




In this study, staphylococci comprised the largest group of bacterial findings both 
in HD and PD patients. As such, these most common bacterial findings did 
not probably originate from the oral cavity. In HD, the most common bacterial finding 
was S. aureus, while coagulase-negative staphylococci (CONS) were the most common 
in PD. Time on HD positively correlated with the number of 
infection episodes, i.e. when dialysis time lengthens, the patient becomes more liable to 
suffer from an infection complication. The same was not found in PD group, however. A 
significant number of both blood (69.1%) and peritoneal fluid (23.1%) samples remained 
negative although patients had been diagnosed with infection. Further study into microbial 
findings should thus be conducted; maybe by using extended culture time as well as 
sensitive molecular methods such as PCR or next-generation sequencing. This approach 
would not only facilitate the recovery of bacteria that are difficult to culture (including certain 
oral bacteria) but would also unveil the as yet uncultured species. 
  
Infection episodes during HD significantly associated with higher salivary levels 
of PGLYRP1, suggesting that selected salivary biomarkers may indicate ongoing systemic 
infection in dialysis patients. Although the main, phyiological functions of PGLYRP1 are 
still ambiguous, PGLYRP1 can be induced in response to systemic infection (Osanai et al., 
2011). Recent work by Silbereisen et al. demonstrated that the levels of PGLYRP-1 
were upregulated in saliva in response to experimental dental plaque 
accumulation (Silbereisen et al., 2019). Although PGLYRP1 has antibacterial activities 
against gram-positive bacteria, the linking of salivary or serum PGYLRP1 to systemic 
infection episodes during HD was not previously demonstrated (Lu et al., 2006; Wang et al., 
2007). Potential correlations between serum and salivary levels of PGLYRP1 in HD patients 
with infection should be further investigated. 
  
Bacteremia episodes or peritoneal infections in dialysis patients were not significantly 
influenced by TDI, PIBI, number of teeth or salivary inflammatory parameters MMP-8, IL-1β, 
and TREM-1 measured at pre-dialysis stage. A study by Lahdentausta et al. recently found 
that while selected salivary biomarkers aided in diagnosis of periodontitis, they did not reflect 
systemic status in acute coronary syndrome patients. Simultaneous serum samples 
reflected the systemic status, but not the periodontal condition (Lahdentausta et al., 2018). 
This result could explain also our results in this regard; salivary biomarkers correlate 
selectively with oral health status, while similar biomarkers obtained from serum could 
reflect systemic inflammation. Nonetheless, studies have shown that calibrated salivary 
diagnostic tools can be used as prediabetes/diabetes screening (Grigoriadis et al., 2019; 
Rathnayake et al., 2013). The recent development of oral fluid, i.e., mouthrinse aMMP-8 
chair-side/point-of-care, diagnostic technology enables the timing and targeting of 
preventive therapeutic interventions against oral infections and related 
inflammation (Grigoriadis et al., 2019; Leppilahti et al., 2018; Sorsa, Gieselmann, Arweiler, 
& Hernández, 2017). More studies are required also in this regard. 
  
In the present study, infection episodes during peritoneal or hemodialysis were not 
significantly associated with oral diseases or salivary inflammatory markers, except for 
PGLYRP1, suggesting that oral condition may not associated with the incidence of 
infections during dialysis. The fact that before commencing dialysis dental treatment had 
been given to the patients may bias this result. However, giving dental treatment was a 
necessity, as kidney transplant timing cannot always be anticipated. Hence, further studies 
with different protocols are called for in this area.  
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N=144 Predialysis stage (2000–2005) 
N=117 Dialysis 
N=71 Hemodialysis N=46 Peritoneal dialysis 
Follow-up stage (2013–2015) 
N=51 kidney transplantation 
N=51 deceased 




N=3 no dialysis 
N=10 dropped out 





Table 1. Micro-organisms detected in blood and peritoneal fluid culture results in 
dialysis patients. 
  
Hemodialysis, N=42 Number (%) Peritoneal dialysis, N=60 Number (%) 





6 (14.3) Staphylococcus aureus 12 (20.0) 
Enterococcus faecalis 3 (7.1) Streptococcus viridans 6 (10.0) 
Corynebacterium jeikeium 3 (7.1) Diphteroids 4 (6.7) 
Beta-hemolytic streptococci 3 (7.1) Acinetobacter spp. 3 (5.0) 
Escherichia coli 2 (4.8) Enterococcus faecalis 3 (5.0) 
Pseudomonas aeruginosa 1 (2.4) Haemophilus-like gram-negative rod 2 (3.3) 
Pseudomonas-like gram-
negative rod 
1 (2.4) Candida albicans 2 (3.3) 
Listeria monocytogenes 1 (2.4) Candida parapsilopsis 1 (1.7) 
Gemella sp. 1 (2.4) Enterobacter cloacae 1 (1.7) 
Diphteroids (excl. C. jeikeium) 1 (2.4) Pseudomonas-like gram-negative 
rod 
1 (1.7) 
    Bacillus cereus 1 (1.7) 
    Micrococcus luteus 1 (1.7) 
*5/6 of the isolates St. epidermidis 







Table 2. Findings in hemodialysis group 
  
  




  Hemodialysis, N=71, 
all patients 
        
      No infections, 
N=27 





55 (26–80)   54 55 0.649 
            
Sex, N (%)         0.110 
Female 21 (30%)   5 (19%) 16 (36%)   
Male 50 (70%)   22 (81%)  28 (64%)   
            
Deceased, N 
(%) 
35 (49.3%)   8 (30%) 27 (61%) 0.009 
            
  Median (IQR*)         
Number of 
teeth 
25 (16–27)   25 (22–27) 23 (11–27) 0.550 
TDI 3 (2–5)   3 (2–4) 3.5 (2–5) 0.760 
PIBI 6 (2–15)   6 (2–15) 5 (1–15) 0.522 
            
  Median pg/mL (IQR*)         
MMP-8 148 (70–203)   112 (70–179) 150 (63–212) 0.393 
PGLYRP1 5825 (2800–10532)   4361 (2264–6632) 8117 (3109–11463) 0.046 
sTREM-1 179 (86–282)   174 (113–274) 185 (51–317) 0.393 
IL-1β 82 (43–140)   72 (52–123) 88 (39–162) 0.393 
Table 3. Findings in peritoneal dialysis group 
  
  
  Peritoneal dialysis 
N=46, 
all patients 
        
      No peritonitis, 
N=17 





51 (23–83)    48   52 0.359 
            
Sex, N (%)         0.894 
Female 13 (28%)   5 (29%) 8 (28%)   
Male 33 (72%)   12 (71%) 21 (72%)   
            
Deceased, N 
(%) 
16 (35%)    6 (35%)  10 (34%) 0.956 
            
  Median (IQR*)         
Number of 
teeth 
27 (21–29)   26 (23–29) 27 (20–28) 0.127 
TDI 3 (2–4)   3 (2–5) 3(3–4) 0.927 
PIBI 5 (2–22)   5 (2–33) 5 (2–14) 0.489 
            
  Median pg/mL (IQR*)         
MMP-8 130 (16–191)   161 (108–188) 78 (14–194) 0.494 
PGLYRP1 6572 (2815–13918)   6518 (3028–13991) 6453 (2344–13782) 0.060 
sTREM-1 193 (65–383)   260 (87–411) 183 (33–329) 0.238 
IL-1β 74 (30–142)   74 (47–155) 22 (24–154) 0.060 
*IQR=interquartile range, lower quartile to upper quartile 
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